Investigating the relationship between Siponimod efficacy in secondary progressive multiple sclerosis and pathogenic Th cell populations

被引：0
|
作者：
Raveney, B. [1 ,2 ]
Katsumoto, A. [2 ,3 ]
Kurosawa, R. [3 ]
Lin, Y. [2 ,3 ]
Takahashi, Y. [3 ]
Okamoto, T. [2 ,3 ]
Oki, S. [1 ]
Sato, W. [1 ,2 ]
Yamamura, T. [1 ,2 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Kodaira, Tokyo, Japan
[2] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Multiple Sclerosis Ctr, Kodaira, Tokyo, Japan
[3] Natl Ctr Neurol & Psychiat, Dept Neurol, Natl Ctr Hosp, Kodaira, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP0939
引用
收藏
页码：774 / 775
页数：2
相关论文
共 50 条
  • [1] Siponimod in secondary progressive multiple sclerosis
    Rissardo, Jamir Pitton
    Caprara, Ana Leticia Fornari
    [J]. INTERNATIONAL ARCHIVES OF HEALTH SCIENCES, 2020, 7 (03) : 155 - 155
  • [2] The EXPAND study results: Efficacy of siponimod in secondary progressive multiple sclerosis
    Vermersch, P.
    Bar-Or, A.
    Cree, B.
    Fox, R.
    Giovannoni, G.
    Gold, R.
    Arnould, S.
    Wallstroem, E.
    Sidorenko, T.
    Wolf, C.
    Dahlke, F.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 44 - 44
  • [3] Siponimod to treat secondary progressive multiple sclerosis
    Gajofatto, A.
    Turatti, M.
    [J]. DRUGS OF TODAY, 2020, 56 (01) : 37 - 46
  • [4] Siponimod for the treatment of secondary progressive multiple sclerosis
    Dumitrescu, Laura
    Constantinescu, Cris S.
    Tanasescu, Radu
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 143 - 150
  • [5] Siponimod for active secondary progressive multiple sclerosis
    Gaber, Tarek
    [J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2021, 25 (02) : 4 - 5
  • [6] Siponimod: A Review in Secondary Progressive Multiple Sclerosis
    Lesley J. Scott
    [J]. CNS Drugs, 2020, 34 : 1191 - 1200
  • [7] Prospects of siponimod in secondary progressive multiple sclerosis
    McGinley, Marisa
    Fox, Robert J.
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [8] Siponimod: A Review in Secondary Progressive Multiple Sclerosis
    Scott, Lesley J.
    [J]. CNS DRUGS, 2020, 34 (11) : 1191 - 1200
  • [9] Efficacy of Siponimod in Secondary Progressive Multiple Sclerosis: Results of the Phase 3 Study
    Kappos, Ludwig
    Bar-Or, Amit
    Cree, Bruce
    Fox, Robert
    Giovannoni, Gavin
    Gold, Ralf
    Vermersch, Patrick
    Arnould, Sophie
    Sidorenko, Tatiana
    Wolf, Christian
    Wallstrom, Erik
    Dahlke, Frank
    [J]. NEUROLOGY, 2017, 88
  • [10] Correction to: Siponimod: A Review in Secondary Progressive Multiple Sclerosis
    Lesley J. Scott
    [J]. CNS Drugs, 2021, 35 : 133 - 133
12345